Combined therapy of imatinib and an anti-CTLA4 immune-checkpoint inhibitor

被引：7
|
作者：
Park, Kinam [1 ]
机构：
[1] Purdue Univ, Biomed Engn & Pharmaceut, W Lafayette, IN 47907 USA
来源：
JOURNAL OF CONTROLLED RELEASE | 2018年 / 281卷
关键词：
D O I：
10.1016/j.jconrel.2018.06.011
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [21] Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
    Munir, Amir Z.
    Gutierrez, Alan
    Qin, Juan
    Lichtman, Andrew H.
    Moslehi, Javid J.
    NATURE REVIEWS CANCER, 2024, 24 (08) : 540 - 553
  • [22] Vogt-Koyanagi-Harada-like syndrome in the setting of combined anti-PD1/anti-CTLA4 therapy
    Godse, R.
    Mcgettigan, S.
    Schuchter, L. M.
    Ellebrecht, C. T.
    Chu, E. Y.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (06) : 1111 - +
  • [23] Immune-Checkpoint Inhibitor Use in Patients with ESKD
    Kitchlu, Abhijat
    Jhaveri, Kenar D.
    Sprangers, Ben
    Yanagita, Motoko
    Wanchoo, Rimda
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 576 - 577
  • [24] Anti-CTLA4 Antibody Therapy Related Complications on FDG PET/CT
    Koo, Phillip J.
    Klingensmith, William C.
    Lewis, Karl D.
    Bagrosky, Brian M.
    Gonzalez, Rene
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (01) : E93 - E96
  • [25] Cutaneous adverse events in tremelimumab, a second-generation anti-CTLA4 inhibitor
    Welborn, Macartney
    Kubicki, Shelby
    Patel, Anisha
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB88 - AB88
  • [26] Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy
    Baumann, Daniel
    Offringa, Rienk
    CELL STRESS, 2020, 4 (10) : 248 - 251
  • [27] New Insights in Mechanism of Action of Anti-CTLA4
    Allison, J.
    Sharma, P.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S23 - S23
  • [28] TREATMENT GUIDELINES FOR THE MANAGEMENT OF IMMUNE-RELATED ADVERSE EVENTS IN PATIENTS TREATED WITH IPILIMUMAB, AN ANTI-CTLA4 THERAPY
    Chin, K.
    Ibrahim, R.
    Berman, D.
    Yellin, M.
    Lowy, I.
    Lin, R.
    Hoos, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 244 - 245
  • [29] Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment
    Ochoa, N. Mongay
    Vogrig, A.
    Castrillo, S. Muniz
    Honnorat, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1170 - 1170
  • [30] Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment
    Mongay-Ochoa, Neus
    Vogrig, Alberto
    Muniz-Castrillo, Sergio
    Honnorat, Jerome
    JOURNAL OF NEUROLOGY, 2020, 267 (07) : 2154 - 2156
12345